Long-term patient outcomes following buprenorphine/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population-Reference-Cited by-同舟云学术

Long-term patient outcomes following buprenorphine/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population

Published:2022-06-07 Issue:4 Volume:48 Page:481-491
ISSN:0095-2990
Container-title:The American Journal of Drug and Alcohol Abuse
language:en
Short-container-title:The American Journal of Drug and Alcohol Abuse

Author:

Hasan Md Mahmudul¹,Noor-E-Alam Md.¹^ORCID,Shi Jiesheng²,Young Leonard D.³,Young Gary J.⁴

Affiliation:

1. Department of Mechanical and Industrial Engineering, College of Engineering, Center for Health Policy and Healthcare Research, Northeastern University, Boston, MA, USA

2. Department of Mechanical and Industrial Engineering, College of Engineering, Northeastern University, Boston, MA, USA

3. Massachusetts Department of Public Health, Prescription Monitoring Program, Boston, MA, USA

4. School of Business, Bouve College of Health Sciences, Center for Health Policy and Healthcare Research, Northeastern UniversityD’Amore-McKim, Boston, MA, USA

Funder

Centers for Disease Control and Prevention

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/00952990.2022.2065638

Reference45 articles.

1. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study

2. Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States

3. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013

4. Economic Costs of Nonmedical Use of Prescription Opioids

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunities;Journal of Substance Use and Addiction Treatment;2024-11

2. An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals;Computers in Biology and Medicine;2024-07

3. Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties;Epidemiology;2024-02-19

4. Endogenous opiates and behavior: 2022;Peptides;2023-11

5. Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D;Frontiers in Psychiatry;2023-04-17